OJPsych  Vol.3 No.2 A , April 2013
Urinary polyomavirus infections in neurodevelopmental disorders
Abstract: We have recently reported enhanced frequencies of polyomavirus infection in post-mortem brain tissue of autistic patients compared to controls. To further explore potential contributions to neurodevelopmental disorders by polyomaviruses, we have employed specie-specific TaqMan assays to assess the prevalence and titres of BKV, JCV and SV40 inthe urines of 87 patients with autism spectrum disorder, 84 controls matched by sex and age with the autistic sample, 15 subjects with Down syndrome and 13 fragile X individuals. Prevalence rates of urinary BKV infection were significantly greater in Down syndrome and fragile X patients compared to autistic and control individuals (P < 0.01). In a large majority of patients who showed the presence of urinary genomes, viral titres resulted significantly higher among Down syndrome patients (P < 0.01) compared to controls, autism spectrum disorder and fragile X individuals, who did not significantly differ from each other. Our results are consistent with previous evidence supporting hampered immunological surveillance and/or immune deficits in fragile X and especially in Down syndrome patients.
Cite this paper: Gentile, I. , Altieri, L. , Lintas, C. , Sacco, R. , Curatolo, P. , Benvenuto, A. , Muratori, F. , Santocchi, E. , Bravaccio, C. , Lenti, C. , Faggioli, R. , Rigardetto, R. , Gandione, M. , Portella, G. , Zappulo, E. , Borgia, G. and Persico, A. (2013) Urinary polyomavirus infections in neurodevelopmental disorders. Open Journal of Psychiatry, 3, 18-25. doi: 10.4236/ojpsych.2013.32A004.

[1]   Lejeune, J., Gautier, M. and Turpin, R. (1959) Study of somatic chromosomes from 9 mongoloid children. Les Comptes Rendus Hebdomadaires des Séances de L’Académie des Sciences, 248, 1721-1722.

[2]   Girirajan, S. (2009) Parental-age effects in Down syndrome. Journal of Genetics, 88, 1-7. doi:10.1007/s12041-009-0001-6

[3]   Yamato, F., Takaya, J., Yasuhara, A., Teraguchi, M., Ikemoto, Y. and Kaneko, K. (2009) Elevated intracellular calcium in neutrophils in patients with Down syndrome. Pediatrics International, 51, 474-477. doi:10.1111/j.1442-200X.2008.02761.x

[4]   de Hingh, Y.C., van der Vossen, P.W., Gemen, E.F., Mulder, A.B., Hop, W.C., Brus, F. and de Vries, E. (2005) Intrinsic abnormalities of lymphocyte counts in children with down syndrome. Journal of Pediatrics, 147, 744-747. doi:10.1016/j.jpeds.2005.07.022

[5]   Ribeiro, L.M., Jacob, C.M., Pastorino, A.C., Kim, C.A., Fomin, A.B. and Castro, A.P. (2003) Evaluation of factors associated with recurrent and/or severe infections in patients with Down’s syndrome. Journal of Pediatrics, 79, 141-148. doi:10.1590/S0021-75572003000200009

[6]   Elsayed, S.M. and Elsayed, G.M. (2009) Phenotype of apoptotic lymphocytes in children with Down syndrome. Immunity & Ageing, 6, 2. doi:10.1186/1742-4933-6-2

[7]   Ait Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L., Creau, N., Blehaut, H., Robin, S., Delabar, J.M. and Potier, M.C. (2007) Classification of human chromosome 21 gene-expression variations in Down syndrome: Impact on disease phenotypes. American Journal of Human Genetics, 81, 475-491. doi:10.1086/520000

[8]   Lockstone, H.E., Harris, L.W., Swatton, J.E., Wayland, M.T., Holland, A.J. and Bahn, S. (2007) Gene expression profiling in the adult Down syndrome brain. Genomics, 90, 647-660. doi:10.1016/j.ygeno .2007.08.005

[9]   Zafeiriou, D.I., Ververi, A. and Vargiami, E. (2007) Childhood autism and associated comorbidities. Brain & Development, 29, 257-272. doi:10.1016/j.braindev.2006.09.003

[10]   Pieretti, M., Zhang, F.P., Fu, Y.H., Warren, S.T., Oostra, B.A., Caskey, C.T. and Nelson, D.L. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66, 817-822. doi:10.1016/0092- 8674(91)90125-I

[11]   Weiler, I.J., Irwin, S.A., Klintsova, A.Y., Spencer, C.M., Brazelton, A.D., Miyashiro, K., Comery, T.A., Patel, B., Eberwine, J. and Greenough, W.T. (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 5395-5400. doi:10.1073/pnas.94.10.5395

[12]   Turner, G., Daniel, A. and Frost, M. (1980) X-linked mental retardation, macro-orchidism, and the Xq27 fragile site. Journal of Pediatrics, 96, 837-841. doi:10.1016/S0022-3476(80)80552-X

[13]   Belmonte, M.K. and Bourgeron, T. (2006) Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neuroscience, 9, 1221-1225. doi:10.1038/nn1765

[14]   American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th Editon, American Psychiatric Press, Washington DC.

[15]   Fombonne, E. (2005) Epidemiology of autistic disorder and other pervasive developmental disorders. Journal of Clinical Psychiatry, 66, 3-8.

[16]   Rutter, M. (2005) Incidence of autism spectrum disorders: Changes over time and their meaning. Acta Paediatrica, 94, 2-15. doi:10.1080/08035250410023124

[17]   Chess, S., Fernandez, P. and Korn, S. (1978) Behavioral consequences of congenital rubella. Journal of Pediatrics, 93, 699-703. doi:10.1016/S0022-3476(78)80921-4

[18]   Christianson, A.L., Chesler, N. and Kromberg, J.G. (1994) Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs. Developmental Medicine & Child Neurology, 36, 361-369. doi:10.1111/j.1469-8749.1994.tb11858.x

[19]   Miller, M.T., Stromland, K., Ventura, L., Johansson, M., Bandim, J.M. and Gillberg, C. (2005) Autism associated with conditions characterized by developmental errors in early embryogenesis: A mini review. International Journal of Developmental Neuroscience, 23, 201-219. doi:10.1016/j. ijdevneu.2004.06.007

[20]   Persico, A.M. and Bourgeron, T. (2006) Searching for ways out of the autism maze: Genetic, epigenetic and environmental clues. Trends in Neurosciences, 29, 349-358. doi:10.1016/j. tins.2006.05.010

[21]   Yamashita, Y., Fujimoto, C., Nakajima, E., Isagai, T. and Matsuishi, T. (2003) Possible association between congenital cytomegalovirus infection and autistic disorder. Journal of Autism and Developmental Disorders, 33, 455-459. doi:10.1023/A:1025023131029

[22]   DiCicco-Bloom, E., Lord, C., Zwaigenbaum, L., Courchesne, E., Dager, S.R., Schmitz, C., Schultz, R.T., Crawley, J. and Young, L.J. (2006) The developmental neurobiology of autism spectrum disorder. Journal of Neuroscience, 26, 6897-6906. doi:10.1523/JNEUROSCI.1712-06.2006

[23]   Libbey, J.E., Sweeten, T.L., McMahon, W.M. and Fujinami, R.S. (2005) Autistic disorder and viral infections. Journal of Neurovirology, 11, 1-10. doi:10.1080/13550280590900553

[24]   van den Pol, A.N. (2006) Viral infections in the developing and mature brain. Trends in Neuroscience, 29, 398-406. doi:10.1080/13550280590900553

[25]   Lintas, C., Altieri, L., Lombardi, F., Sacco, R. and Persico, A.M. (2010) Association of autism with polyomavirus infection in postmortem brains. Journal of Neurovirology, 16, 141-149. doi:10.3109/13550281003685839

[26]   Ding, R., Medeiros, M., Dadhania, D., Muthukumar, T., Kracker, D., Kong, J.M., Epstein, S.R., Sharma, V.K., Seshan, S.V., Li, B. and Suthanthiran, M. (2002) Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation, 74, 987-994.

[27]   Randhawa, P., Shapiro, R. and Vats, A. (2005) Quantitation of DNA of polyomaviruses BK and JC in human kidneys. Journal of Infectious Diseases, 192, 504-509. doi:10.1086/431522

[28]   Pal, A., Sirota, L., Maudru, T., Peden, K. and Lewis Jr., A.M. (2006) Real-time, quantitative PCR assays for the detection of virus-specific DNA in samples with mixed populations of polyomaviruses. Journal of Virological Methods, 135, 32-42. doi:10.1016/j.jviromet.2006.01.018

[29]   Knowles, W. (2006) Discovery and epidemiology of the human polyomaviruses BK Virus (BKV) and JC Virus (JCV) in Polyomaviruses and Human Disease. In: Ahsan, N., Ed., Advances in Experimental Medicine and Biology, Landes Bioscience, Georgetown, 117-147. doi:10.1007/0-387-32957-9_2

[30]   Zhong, S., Zheng, H.Y., Suzuki, M., Chen, Q., Ikegaya, H., Aoki, N., Usuku, S., Kobayashi, N., Nukuzuma, S., Yasuda, Y., Kuniyoshi, N., Yogo, Y. and Kitamura, T. (2007) Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. Journal of Clinical Microbiology, 45, 193-198. doi:10.1128/JCM.01645-06

[31]   Vanchiere, J.A., White, Z.S. and Butel, J.S. (2005) Detection of BK virus and simian virus 40 in the urine of healthy children. Journal of Medical Virology, 75, 447-454. doi:10.1002/jmv.20287

[32]   Garrison, M.M., Jeffries, H. and Christakis, D.A. (2005) Risk of death for children with down syndrome and sepsis. Journal of Pediatrics, 147, 748-752. doi:10.1016/j.jpeds.2005.06.032

[33]   Avanzini, M.A., Monafo, V., De Amici, M., Maccario, R., Burgio, G.R., Plebani, A., Ugazio, A.G. and Hanson, L.A. (1990) Humoral immunodeficiencies in Down syndrome: Serum IgG subclass and antibody response to hepatitis B vaccine. American Journal of Medical Genetics, 7, 231-233.

[34]   Costa-Carvalho, B.T., Martinez, R.M., Dias, A.T., Kubo, C.A., Barros-Nunes, P., Leiva, L., Sole, D., CarneiroSampaio, M.M., Naspitz, C.K. and Sorensen, R.U. (2006) Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Brazilian Journal of Medical and Biological Research, 39, 1587-1592. doi:10.1590/S0100-879X2006005000047

[35]   Epstein, L.B. and Philip, R. (1987) Abnormalities of the immune response to influenza antigen in Down syndrome (trisomy 21). Progress in Clinical Biological Research, 246, 163-182.

[36]   Ferreira, C.T., Leite, J.C., Taniguchi, A., Vieira, S.M., Pereira-Lima, J. and da Silveira, T.R. (2004) Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. Journal of Pediatric Gastroenterology and Nutrition, 39, 337-340. doi:10.1097/00005176-200410000-00007

[37]   Philip, R., Berger, A.C., McManus, N.H., Warner, N.H., Peacock, M.A. and Epstein, L.B. (1986) Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). Journal of Immunology, 136, 1661-1667.

[38]   Burgio, G.R., Lanzavecchia, A., Maccario, R., Vitiello, A., Plebani, A. and Ugazio, A.G. (1978) Immunodeficiency in Down’s syndrome: T-lymphocyte subset imbalance in trisomic children. Clinical & Experimental Immunology, 33, 298-301.

[39]   Verstegen, R.H., Kusters, M.A., Gemen, E.F., et al. (2010) Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatric Research, 67, 563-569. doi:10.1203/PDR.0b013e3181d4ecc1

[40]   Cossarizza, A., Monti, D., Montagnani, G., Ortolani, C., Masi, M., Zannotti, M. and Franceschi, C. (1990) Precocious aging of the immune system in Down syndrome: Alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. American Journal of Medical Genetics, 7, 213-218.

[41]   Lockitch, G., Singh, V.K., Puterman, M.L., Godolphin, W.J., Sheps, S., Tingle, A.J., Wong, F. and Quigley, G. (1987) Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatric Research, 22, 536-540. doi:10.1203/00006450-198711000-00013

[42]   Hagerman, R.J. and Hagerman, P.J. (2002) Fragile X syndrome: Diagnosis, treatment and research. 3rd Edition, T.J.H.U. Press, Baltimore.

[43]   Ashwood, P., Nguyen, D.V., Hessl, D., Hagerman, R.J. and Tassone, F. (2010) Plasma cytokine profiles in fragile X subjects: Is there a role for cytokines in the pathogenesis? Brain, Behavior, and Immunity, 24, 898-902. doi:10.1016/j.bbi.2010.01.008

[44]   Abrahams, B.S. and Geschwind, D.H. (2008) Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics, 9, 341-355. doi:10.1038/nrg2346

[45]   Freitag, C.M. (2007) The genetics of autistic disorders and its clinical relevance: A review of the literature. Molecular Psychiatry, 12, 2-22. doi:10.1038/

[46]   Weiss, L.A. (2009) Autism genetics: Emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Review of Molecular Diagnostics, 9, 795-803. doi:10.1586/ erm.09.59

[47]   Lintas, C. and Persico, A.M. (2009) Autistic phenotypes and genetic testing: State-of-the-art for the clinical geneticist. Journal of Medical Genetics, 46, 1-8. doi:10.1136/jmg.2008.060871

[48]   Persico, A.M. (2010) Polyomaviruses and autism: More than simple association? Journal of Neurovirology, 16, 332-333. doi:10.3109/13550284.2010.504765

[49]   Garbett, K., Ebert, P.J., Mitchell, A., Lintas, C., Manzi, B., Mirnics, K. and Persico, A.M. (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiology of Disease, 30, 303-311. doi:10.1016/j.nbd.2008.01.012

[50]   Lintas, C., Sacco, R., Garbett, K., Mirnics, K., Militerni, R., Bravaccio, C., Curatolo, P., Manzi, B., Schneider, C., Melmed, R., Elia, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.L. and Persico, A.M. (2009) Involvement of the PRKCB1 gene in autistic disorder: Significant genetic association and reduced neocortical gene expression. Molecular Psychiatry, 14, 705-718. doi:10.1038/mp.2008.21

[51]   Palmieri, L., Papaleo, V., Porcelli, V., Scarcia, P., Gaita, L., Sacco, R., Hager, J., Rousseau, F., Curatolo, P., Manzi, B., Militerni, R., Bravaccio, C., Trillo, S., Schneider, C., Melmed, R., Elia, M., Lenti, C., Saccani, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.L. and Persico, A.M. (2010) Altered calcium homeostasis in autism-spectrum disorders: Evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Molecular Psychiatry, 15, 38-52. doi:10.1038/mp.2008.63

[52]   Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W. and Pardo, C.A. (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67-81. doi:10.1002/ana.20315

[53]   Ashwood, P., Wills, S. and Van de Water, J. (2006) The immune response in autism: A new frontier for autism research. Journal of Leukocyte Biology, 80, 1-15. doi:10.1189/jlb.1205707

[54]   Boddaert, N., Zilbovicius, M., Philipe, A., Robel, L., Bourgeois, M., Barthelemy, C., Seidenwurm, D., Meresse, I., Laurier, L., Desguerre, I., Bahi-Buisson, N., Brunelle, F., Munnich, A., Samson, Y., Mouren, M.C. and Chabane, N. (2009) MRI findings in 77 children with non-syndromic autistic disorder. PLoS One, 4, 10. doi:10.1371/journal.pone.0004415

[55]   Cacciotti, P., Libener, R., Betta, P., Martini, F., Porta, C., Procopio, A., Strizzi, L., Penengo, L., Tognon, M., Mutti, L. and Gaudino, G. (2001) SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma. Proceedings of the National Academy of Sciences of the United States of America, 98, 12032-12037. doi:10.1073/pnas.211026798

[56]   Campbell, D.B., Sutcliffe, J.S., Ebert, P.J., Militerni, R., Bravaccio, C., Trillo, S., Elia, M., Schneider, C., Melmed, R., Sacco, R., Persico, A.M. and Levitt, P. (2006) A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences of the United States of America, 103, 16834-16839. doi:10.1073/pnas.0605296103

[57]   Pass, R.F., Stagno, S., Britt, W.J. and Alford, C.A. (1983) Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. Journal of Infectious Diseases, 148, 953-961. doi:10.1093/infdis/148.6.953

[58]   Noyola, D.E., Demmler, G.J., Williamson, W.D., Griesser, C., Sellers, S., Llorente, A., Littman, T., Williams, S., Jarrett, L., Yow, M.D. and Congenital CMV Longitudinal Study Group (2000) Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Pediatric Infectious Disease Journal, 19, 505-510. doi:10.1097/00006454-200006000-00003